$HYPR News

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference

Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans

Hyperfine Announces Peer-Reviewed Publication Of NEURO PMR Study In Journal Of Neuroimaging

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

Hyperfine Receives FDA Clearance For Its Latest Optive AI Software Update; Plans Rollout Of New Software In The U.S. In September

Hyperfine (HYPR) Q2 2026 Earnings Call Transcript

Hyperfine, Inc. 2026 Q2 - Results - Earnings Call Presentation

B. Riley Securities Reiterates Buy on Hyperfine, Lowers Price Target to $1.6

Hyperfine, Inc. Q2 2026 Earnings Call Summary

Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript

Hyperfine Inc (HYPR) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% on Strong System ...

Hyperfine Q2 Earnings Call Highlights

Hyperfine (NASDAQ:HYPR) Q2 Revenue Misses as EPS Matches, But Full-Year Guidance Midpoint Exceeds Estimates

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

Hyperfine Affirms FY2026 Sales Guidance of $20.000M-$22.000M vs $20.163M Est

Hyperfine Q2 EPS $(0.09), Inline, Sales $3.904M Miss $4.143M Estimate

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

Hyperfine Announces European Launch Of Its Swoop Portable MRI System Powered By Optive AI Software

Hyperfine launches next-generation Swoop MRI system in Europe